EUCROF26, the 9th Annual EUCROF Conference, will convene clinical research professionals in Amsterdam to explore innovation in trials, AI, decentralization, and patient‑centric models. With expert panels, workshops, and networking, the event fosters collaboration among CROs, sponsors, regulators, and innovators, shaping the future of drug development and clinical excellence.

The SCOPE Summit 2026 in Orlando is a premier global event for clinical trial operations, offering unparalleled networking, 32 specialized tracks, and cutting‑edge insights into AI, patient engagement, and pharmacovigilance.

2nd Proteomic‑Based Drug Discovery Summit in Boston unites global experts to explore proteomics in drug discovery, biomarker identification, and personalized medicine. With workshops, case studies, and networking, the event highlights mass spectrometry, chemoproteomics, and AI applications, offering a premier platform for collaboration between academia, biotech, and pharmaceutical industries.

The 14th Alzheimer’s & Parkinson’s Drug Development Summit in Boston unites pharma, biotech, and academia to advance disease-modifying therapies. With 40+ speakers, biomarker innovation sessions, patient panels, and 10+ hours of networking, it is the premier forum for tackling neurodegenerative challenges and shaping the future of Alzheimer’s and Parkinson’s treatment.

The 9th Annual Pharma Project & Portfolio Management Conference is a premier industry forum for pharmaceutical project leaders, portfolio managers, R&D strategists, PMOs, legal/IP experts, and senior executives. It features expert-led sessions, live case studies, soft-skill workshops, interactive Q&A, and networking to address challenges in project delivery, portfolio optimization, and strategic execution excellence.

CTIP 2026 is a premier European clinical trials conference focused on innovation in trial design, execution, patient-centric research, digital health, and operational excellence. Over two days, industry leaders share insights on AI, adaptive trials, data integrity, and streamlined operations while facilitating networking, expert talks, and practical sessions for pharma, biotech, CROs, and research professionals.

The 6th Annual Psychedelic Therapeutics & Drug Development Conference brings together researchers, clinicians, industry leaders, and regulators to explore scientific advances, clinical trial design, regulatory strategies, and commercialization of psychedelic-based therapies for conditions such as PTSD, depression, pain, addiction, and neuropsychiatric disorders. It offers networking, industry insights, and practical guidance for drug development stakeholders.

Clinical Trials Summit 2026 in Mumbai unites pharma, biotech, CROs, and regulators to explore innovations in trial design, patient recruitment, and digital transformation. With keynotes, panels, and networking, the event provides a premier platform for advancing clinical research, ensuring compliance, and shaping the future of drug development in India and globally.

The 2nd Annual Clinical Trials Series 2026 in Bengaluru unites pharma, biotech, CROs, and regulators to explore innovations in trial design, patient recruitment, and digital transformation. With keynotes, panels, and networking, the event provides a premier platform for advancing clinical research, ensuring compliance, and shaping the future of drug development in India and globally.